Gadobutrol 70436-0212
Product NDC
70436-0212- Manufacturer
- Slate Run Pharmaceuticals, Llc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 20, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA217480
Need to source Gadobutrol? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Gadobutrol | 604.72 mg/mL |
Drug Class
Gadolinium-based Contrast Agent [EPC]Gadolinium-based Contrast Agent [EPC]Magnetic Resonance Contrast Activity [MoA]
Packaging Options(2)
20 VIAL, SINGLE-DOSE in 1 CARTON (70436-212-54) / 7.5 mL in 1 VIAL, SINGLE-DOSE (70436-212-32)
1 VIAL, SINGLE-DOSE in 1 CARTON (70436-212-80) / 7.5 mL in 1 VIAL, SINGLE-DOSE (70436-212-32)